title: Dopaminergic Differentiation of Human Embryonic Stem Cells on PA6-Derived Adipocytes.
abstract: Human embryonic stem cells (hESCs) are a promising source for cell replacement therapies. Parkinson's disease is one of the candidate diseases for the cell replacement therapy since the motor manifestations of the disease are associated with the loss of dopaminergic neurons in the substantia nigra pars compacta. Stromal cell-derived inducing activity (SDIA) is the most commonly used method for the dopaminergic differentiation of hESCs. This chapter describes a simple, reliable, and scalable dopaminergic induction method of hESCs using PA6-derived adipocytes. Coculturing hESCs with PA6-derived adipocytes markedly reduces the variable outcomes among experiments. Moreover, the colony differentiation step of this method can also be used for the dopaminergic induction of mouse embryonic stem cells and NTERA2 cells as well.
authors.affiliation: Department of Experimental Medical Science, Faculty of Medicine, Lund University, 22184, Lund, Sweden. Oktar.Guloglu@med.lu.se.
authors.forename: M Oktar
authors.initials: MO
authors.lastname: Guloglu
authors.affiliation: Department of Experimental Medical Science, Faculty of Medicine, Lund University, 22184, Lund, Sweden.
authors.forename: Anna
authors.initials: A
authors.lastname: Larsen
mesh_terms: D017667:Adipocytes / Q000166:cytology*; D050156:Adipogenesis; D018920:Coculture Techniques / Q000379:methods*; D059290:Dopaminergic Neurons / Q000166:cytology*; D000066449:Human Embryonic Stem Cells / Q000166:cytology*; D006801:Humans; D058953:Neural Stem Cells / Q000166:cytology*; D055495:Neurogenesis
keywords: Adipocytes; Dopaminergic differentiation; Human embryonic stem cells; Parkinson’s disease; SDIA